CYTX - Cytori Therapeutics, Inc.

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
0.354
-0.027 (-7.013%)
At close: 3:59PM EST
Stock chart is not supported by your current browser
Previous Close0.381
Open0.400
Bid0.000 x 0
Ask0.000 x 0
Day's Range0.340 - 0.410
52 Week Range0.220 - 2.130
Volume1,921,689
Avg. Volume1,177,262
Market Cap12.432M
Beta2.86
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • SmarterAnalyst10 days ago

    Here’s Why Cytori Therapeutics Inc (CYTX) Shares Skyrocketed Today

    Cytori Therapeutics Inc (NASDAQ:CYTX) was Wall Street's bull of the day today with shares that flew 74%. The cause of all the enthusiastic commotion? Japanese drug giant Takeda Pharmaceutical intends to acquire TiGenix, an advanced biopharmaceutical company developing novel stem cell therapies for serious medical conditions, at an acquisition price of EUR 1.78 per share, representing a transaction value of approximately EUR 520 million on a fully diluted basis. Investors see the acquisition of Tigenix as a positive "interest" signal for the regenerative medicine space and specifically for Cytori which has a similar adipose based product.

  • Capital Cube29 days ago

    ETFs with exposure to Cytori Therapeutics, Inc. : December 18, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Cytori Therapeutics, Inc. Here are 5 ETFs with the largest exposure to CYTX-US. Comparing the performance and risk of Cytori Therapeutics, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Cytori Therapeutics Inc’s (CYTX) Earnings Declined 36.4%, But How Did It Fare Against The Industry?
    Simply Wall St.2 months ago

    Cytori Therapeutics Inc’s (CYTX) Earnings Declined 36.4%, But How Did It Fare Against The Industry?

    Understanding Cytori Therapeutics Inc’s (NASDAQ:CYTX) performance as a company requires examining more than earnings from one point in time. Today I will take you through a basic sense check toRead More...

  • Capital Cube2 months ago

    ETFs with exposure to Cytori Therapeutics, Inc. : November 27, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Cytori Therapeutics, Inc. Here are 5 ETFs with the largest exposure to CYTX-US. Comparing the performance and risk of Cytori Therapeutics, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Cytori Therapeutics, Inc. :CYTX-US: Earnings Analysis: Q3, 2017 By the Numbers : November 21, 2017
    Capital Cube2 months ago

    Cytori Therapeutics, Inc. :CYTX-US: Earnings Analysis: Q3, 2017 By the Numbers : November 21, 2017

    Categories: Yahoo FinanceGet free summary analysis Cytori Therapeutics, Inc. reports financial results for the quarter ended September 30, 2017. We analyze the earnings along side the following peers of Cytori Therapeutics, Inc. – Baxter International Inc., Retractable Technologies, Inc., Vericel Corporation, Haemonetics Corporation, CryoLife, Inc., Cesca Therapeutics Inc., Caladrius Biosciences, Inc. and Cerus Corporation (BAX-US, RVP-US, VCEL-US, ... Read more (Read more...)

  • Thomson Reuters StreetEvents2 months ago

    Edited Transcript of CYTX earnings conference call or presentation 9-Nov-17 10:30pm GMT

    Q3 2017 Cytori Therapeutics Inc Earnings Call

  • Associated Press2 months ago

    Cytori reports 3Q loss

    On a per-share basis, the San Diego-based company said it had a loss of 14 cents. The developer of cell therapies posted revenue of $1.8 million in the period. In the final minutes of trading on Thursday, ...

  • Capital Cube2 months ago

    ETFs with exposure to Cytori Therapeutics, Inc. : November 6, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Cytori Therapeutics, Inc. Here are 5 ETFs with the largest exposure to CYTX-US. Comparing the performance and risk of Cytori Therapeutics, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Should You Buy Cytori Therapeutics Inc (CYTX) Now?
    Simply Wall St.3 months ago

    Should You Buy Cytori Therapeutics Inc (CYTX) Now?

    Cytori Therapeutics Inc (NASDAQ:CYTX), a biotechnology company based in United States, received a lot of attention from a substantial price increase on the NasdaqCM in the over the last fewRead More...

  • Capital Cube3 months ago

    ETFs with exposure to Cytori Therapeutics, Inc. : October 9, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Cytori Therapeutics, Inc. Here are 5 ETFs with the largest exposure to CYTX-US. Comparing the performance and risk of Cytori Therapeutics, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Capital Cube4 months ago

    ETFs with exposure to Cytori Therapeutics, Inc. : September 27, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Cytori Therapeutics, Inc. Here are 5 ETFs with the largest exposure to CYTX-US. Comparing the performance and risk of Cytori Therapeutics, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Capital Cube4 months ago

    ETFs with exposure to Cytori Therapeutics, Inc. : September 7, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Cytori Therapeutics, Inc. Here are 5 ETFs with the largest exposure to CYTX-US. Comparing the performance and risk of Cytori Therapeutics, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Capital Cube5 months ago

    ETFs with exposure to Cytori Therapeutics, Inc. : August 25, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Cytori Therapeutics, Inc. Here are 5 ETFs with the largest exposure to CYTX-US. Comparing the performance and risk of Cytori Therapeutics, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • TheStreet.com5 months ago

    Biotech Movers: Red Hill Jumps After Securing Rights Sell GERD Treatment

    A number of biotech-related stocks were down pre-market after announcing plans for public offerings.

  • Cytori Therapeutics, Inc. :CYTX-US: Earnings Analysis: Q2, 2017 By the Numbers : August 16, 2017
    Capital Cube5 months ago

    Cytori Therapeutics, Inc. :CYTX-US: Earnings Analysis: Q2, 2017 By the Numbers : August 16, 2017

    Categories: Yahoo FinanceGet free summary analysis Cytori Therapeutics, Inc. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of Cytori Therapeutics, Inc. – Athersys, Inc., Baxter International Inc., Retractable Technologies, Inc., Vericel Corporation, Haemonetics Corporation, CryoLife, Inc., Caladrius Biosciences, Inc. and Cerus Corporation (ATHX-US, BAX-US, RVP-US, VCEL-US, ... Read more (Read more...)

  • Thomson Reuters StreetEvents5 months ago

    Edited Transcript of CYTX earnings conference call or presentation 10-Aug-17 9:30pm GMT

    Q2 2017 Cytori Therapeutics Inc Earnings Call

  • Associated Press5 months ago

    Cytori reports 2Q loss

    On a per-share basis, the San Diego-based company said it had a loss of 19 cents. Losses, adjusted for amortization costs, were 18 cents per share. The developer of cell therapies posted revenue of $1.5 ...

  • SmarterAnalyst6 months ago

    Analysts Remain Buyers of 2 Volatile Healthcare Stocks: Cytori Therapeutics Inc (CYTX) and TearLab Corp (TEAR)

    Cytori Therapeutics Inc: Should You Catch This Falling Knife? Cytori Therapeutics Inc (NASDAQ:CYTX) shares are crashing over 60% in Monday's trading session, after the biotech company disclosed that its pivotal STAR study assessing Habeo Cell Therapy for the treatment of scleroderma failed to achieve its primary endpoint at week 24 nor any of its secondary endpoints at week 24 or week 48. Kolbert noted, "The totality of the data combined with the investigator comments matter and suggest to us that there maybe a window for approval based on the current data set and/or a small bridging study.

  • Zacks6 months ago

    Are Options Traders Betting on a Big Move in Cytori Therapeutics (CYTX) Stock?

    Investors in Cytori Therapeutics, Inc. (CYTX) need to pay close attention to the stock based on moves in the options market lately.

  • Capital Cube6 months ago

    ETFs with exposure to Cytori Therapeutics, Inc. : July 5, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Cytori Therapeutics, Inc. Here are 5 ETFs with the largest exposure to CYTX-US. Comparing the performance and risk of Cytori Therapeutics, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Capital Cube7 months ago

    ETFs with exposure to Cytori Therapeutics, Inc. : June 6, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Cytori Therapeutics, Inc. Here are 5 ETFs with the largest exposure to CYTX-US. Comparing the performance and risk of Cytori Therapeutics, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Cytori Therapeutics, Inc. :CYTX-US: Earnings Analysis: Q1, 2017 By the Numbers : May 24, 2017
    Capital Cube8 months ago

    Cytori Therapeutics, Inc. :CYTX-US: Earnings Analysis: Q1, 2017 By the Numbers : May 24, 2017

    Categories: Yahoo FinanceGet free summary analysis Cytori Therapeutics, Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Cytori Therapeutics, Inc. – Athersys, Inc., Baxter International Inc., Retractable Technologies, Inc., Vericel Corporation, Haemonetics Corporation, CryoLife, Inc., Cesca Therapeutics Inc., Caladrius Biosciences, Inc. and Cerus Corporation (ATHX-US, ... Read more (Read more...)

  • Thomson Reuters StreetEvents8 months ago

    Edited Transcript of CYTX earnings conference call or presentation 11-May-17 9:30pm GMT

    Q1 2017 Cytori Therapeutics Inc Earnings Call

  • Associated Press8 months ago

    Cytori reports 1Q loss

    The San Diego-based company said it had a loss of 33 cents per share. Losses, adjusted for non-recurring costs, came to 26 cents per share. The developer of cell therapies posted revenue of $1.6 million ...

  • TheStreet.com9 months ago

    Cytori Therapeutics Stock Sliding on Offering Price Discount

    Cytori Therapeutics stock is sinking after the biotech company priced a stock offering at steep discount.